Evidence map›Paper›PMID 40952793›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2026

Impact of Computed Tomography-Derived Body Composition Analysis on the Performance of GFR Estimating Equations in Patients with Cancer.

Verônica T Costa E Silva, Meghan E Sise, Lesley A Inker, Lea Mantz, Tianqi Ouyang, Fernando Louzada Strufaldi, Luiz A Gil-Jr, Renato A Caires, George Coura-Filho, Marcelo T Sapienza and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Beyond Creatinine: A New Era of GFR Assessment in Patients with Cancer.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Verônica T Costa E SilvaServiço de Nefrologia, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil.ORCID 0000-0001-8211-018
Meghan E SiseDivision of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Lesley A InkerDivision of Nephrology, Tufts Medical Center, Boston, Massachusetts.ORCID 0000-0003-2820-9482
Lea MantzDepartment of Radiology, Massachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0003-0998-8812
Tianqi OuyangDivision of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Fernando Louzada StrufaldiLaboratório de Investigação Médica (LIM) 16, Serviço de Nefrologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil.ORCID 0000-0001-9682-3498
Luiz A Gil-JrLaboratório de Investigação Médica (LIM) 66, Serviço de Geriatria, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil.ORCID 0000-0002-2027-5170
Renato A CairesServiço de Nefrologia, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil.
George Coura-FilhoServiço de Medicina Nuclear, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil.ORCID 0000-0003-3219-1035
Marcelo T SapienzaLaboratório de Medicina Nuclear (LIM43), Instituto de Radíologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.ORCID 0000-0001-9766-6332
Emmanuel A BurdmannLaboratório de Investigação Médica (LIM) 12, Serviço de Nefrologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.ORCID 0000-0002-7644-8579
Florian J FintelmannDepartment of Radiology, Massachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0002-0119-3903

Funding

Mechanisms driving acute and chronic kidney function decline after immune checkpoint inhibitor therapy for cancerR01DK130839 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Meghan E. Sise · 2022 to 2026
$3.6M
Rapid Diagnosis and Treatment Response Phenotyping of Immune Checkpoint Inhibitor-Associated Acute Interstitial NephritisR01DK140717 · NIDDK · YALE UNIVERSITY · PI Dennis G. Moledina, Meghan E. Sise · 2024 to 2026
$2.9M
Fundação de Amparo à Pesquisa do Estado de São Paulo 2014/19286-4NIDDK NIH HHS R01 DK130839NIDDK NIH HHS R01 DK140717NIH HHS 01DK130839 and R01DK140717
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

glomerular filtration rateonconephrology

Identifiers

PMID40952793
PMCPMC12889952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.